Haemonetics Corp. (HAE) Tops Q4 EPS by 2c; Guides FY14 EPS Above Views
Tweet Send to a Friend
Haemonetics Corp. (NYSE: HAE) reported Q4 EPS of $0.48, $0.02 better than ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
